Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Operating Income

Profit from core operations after operating expenses, before interest and taxes.

No reported Operating Income figures are available to summarize.

Operating Income history

Currency unavailable · from the income statement

No Operating Income data reported for this period type.

Operating Income vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Operating Income for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$58.34M USD+143.3%—20.7%
ANABAnaptysBio, Inc.LTM Mar 2026$40.8M USD+140.7%—17.6%
AGMBAgomAb Therapeutics N.V. American Depositary SharesFY2024-€48.02M EUR-54.0%——
ACRSAclaris Therapeutics, Inc.LTM Mar 2026-$80.48M USD+43.0%—961.9%
IMUXImmunic, Inc.LTM Mar 2026-$109.64M USD-8.6%——
ORKAOruka Therapeutics, Inc.LTM Sep 2026-$183.11M USD-45.4%——
SYRESpyre Therapeutics, Inc.LTM Sep 2026-$250.17M USD-17.1%—276.5%
ALMSAlumis Inc. Common StockLTM Jun 2026-$459M USD-4.5%—6204.4%
ODTXOdyssey Therapeutics, Inc.—— ———
Peer median (excluding ODTX) —-6.5%—276.5%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.